Age and equity in liver transplantation: An organ allocation model

A moral liver allocation policy must be fair. We considered a 2‐step, 2‐principle allocation system called “age mapping.” Its first principle, equal opportunity, ensures that candidates of all ages have an equal chance of getting an organ. Its second principle, prudential lifespan equity, allocates younger donor grafts to younger candidates and older donors to older candidates in order to increase the likelihood that all recipients achieve a “full lifespan.” Data from 2476 candidates and 1371 consecutive adult liver transplantations (from 1999 to 2012) were used to determine whether age mapping can reduce the gap in years of life lost (YLL) between younger and older recipients. A parametric Weibull prognostic model was developed to estimate total life expectancy after transplantation using survival of the general population matched by sex and age as a reference. Life expectancy from birth was calculated by adding age at transplant and total life expectancy after transplantation. In multivariate analysis, recipient age, hepatitis C virus status, Model for End‐Stage Liver Disease score at transplant of >30, and donor age were significantly related to prognosis after surgery (P < 0.05). The mean (and standard deviation) number of years of life from birth, calculated from the current allocation model, for various age groups were: recipients 18‐47 years (n = 340) = 65.2 (3.3); 48‐55 years (n = 387) = 72.7 (2.1); 56‐61 years (n = 372) = 74.7 (1.7) and for recipients >61 years (n = 272) = 77.4 (1.4). The total number of YLL equaled 523 years. Redistributing liver grafts, using an age mapping algorithm, reduces the lifespan gap between younger and older candidates by 33% (from 12.3% to 8.3%) and achieves a 14% overall reduction of YLL (73 years) compared to baseline liver distribution. In conclusion, deliberately incorporating age into an allocation algorithm promotes fairness and increases efficiency. Liver Transpl 21:1241‐1249, 2015. © 2015 AASLD.

[1]  V. Mazzaferro,et al.  Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  M. Volk,et al.  A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. , 2014, Journal of hepatology.

[3]  A. Cucchetti,et al.  Can liver transplantation provide the statistical cure? , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  P. Das,et al.  The story of GBD 2010: a “super-human” effort , 2012, The Lancet.

[5]  R. Merion,et al.  Factors that affect deceased donor liver transplantation rates in the United States in addition to the model for end‐stage liver disease score , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  L. Ross,et al.  Age Should Not Be Considered in the Allocation of Deceased Donor Kidneys , 2012, Seminars in dialysis.

[7]  L. Ross,et al.  Equal Opportunity Supplemented by Fair Innings: Equity and Efficiency in Allocating Deceased Donor Kidneys , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  T. Perneger,et al.  A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list , 2012, Hepatology.

[9]  A. Burroughs,et al.  The evolution in the prioritization for liver transplantation , 2012, Annals of gastroenterology.

[10]  A. Gasbarrini,et al.  Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D‐MELD With Particular Reference to HCV Recipients , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  J J Fung,et al.  Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  M. Masetti,et al.  Survival Benefit After Liver Transplantation: A Single European Center Experience , 2009, Transplantation.

[13]  M. Aldersley,et al.  Donor Risk Index and MELD Interactions in Predicting Long-Term Graft Survival: A Single-Centre Experience , 2009, Transplantation.

[14]  J. Kalbfleisch,et al.  Survival Benefit‐Based Deceased‐Donor Liver Allocation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  E. Emanuel,et al.  Principles for allocation of scarce medical interventions , 2009, The Lancet.

[16]  S. Brauer,et al.  Age rationing and prudential lifespan account in Norman Daniels’ Just health , 2008, Journal of Medical Ethics.

[17]  L. Bolondi,et al.  Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  Daniels Ma,et al.  „Just Health: Meeting Health Needs Fairly“* , 2008, Ethik in der Medizin.

[19]  Paul W Dickman,et al.  Estimating and modeling the cure fraction in population-based cancer survival analysis. , 2007, Biostatistics.

[20]  J. Neuberger,et al.  Life expectancy of adult liver allograft recipients in the UK , 2006, Gut.

[21]  M. Rugge,et al.  Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma , 2004, Annals of surgery.

[22]  A. Williams,et al.  Intergenerational equity: an exploration of the 'fair innings' argument. , 1997, Health economics.

[23]  F. Newell What Kind of Life. The Limits of Medical Progress , 1990 .

[24]  J. Harris QALYfying the value of life. , 1987, Journal of medical ethics.

[25]  Dan W. Brockt,et al.  The Theory of Justice , 2017 .

[26]  P. Terasaki,et al.  Liver transplantation in the United States. , 2005, Clinical transplants.

[27]  S. Finder,et al.  Transplantation Ethics , 2001, Annals of Internal Medicine.